TY - JOUR
T1 - From Real-World Data to Causally Interpretable Models
T2 - A Bayesian Network to Predict Cardiovascular Diseases in Adolescents and Young Adults with Breast Cancer
AU - Bernasconi, Alice
AU - Zanga, Alessio
AU - Lucas, Peter J.F.
AU - Scutari, Marco
AU - Di Cosimo, Serena
AU - De Santis, Maria Carmen
AU - La Rocca, Eliana
AU - Baili, Paolo
AU - Cavallo, Ilaria
AU - Verderio, Paolo
AU - Ciniselli, Chiara M.
AU - Pizzamiglio, Sara
AU - Blanda, Adriana
AU - Perego, Paola
AU - Vallerio, Paola
AU - Stella, Fabio
AU - Trama, Annalisa
AU - The Ada Working Group
N1 - Publisher Copyright:
© 2024 by the authors.
PY - 2024/11
Y1 - 2024/11
N2 - Background: In the last decades, the increasing number of adolescent and young adult (AYA) survivors of breast cancer (BC) has highlighted the cardiotoxic role of cancer therapies, making cardiovascular diseases (CVDs) among the most frequent, although rare, long-term sequalae. Leveraging innovative artificial intelligence (AI) tools and real-world data (RWD), we aimed to develop a causally interpretable model to identify young BC survivors at risk of developing CVDs.Methods: We designed and trained a Bayesian network (BN), an AI model, making use of expert knowledge and data from population-based (1036 patients) and clinical (339 patient) cohorts of female AYA (i.e., aged 18 to 39 years) 1-year survivors of BC, diagnosed in 2009–2019. The performance achieved by the BN model was validated against standard classification metrics, and two clinical applications were proposed.Results: The model showed a very good classification performance and a clear causal semantic. According to the predictions made by the model, focusing on the 25% of AYA BC survivors at higher risk of developing CVDs, we could identify 81% of the patients who would actually develop it. Moreover, a desktop-based app was implemented to calculate the individual patient’s risk.Conclusions: In this study, we developed the first causal model for predicting the CVD risk in AYA survivors of BC, also proposing an innovative AI approach that could be useful for all researchers dealing with RWD. The model could be pivotal for clinicians who aim to plan personalized follow-up strategies for AYA BC survivors.
AB - Background: In the last decades, the increasing number of adolescent and young adult (AYA) survivors of breast cancer (BC) has highlighted the cardiotoxic role of cancer therapies, making cardiovascular diseases (CVDs) among the most frequent, although rare, long-term sequalae. Leveraging innovative artificial intelligence (AI) tools and real-world data (RWD), we aimed to develop a causally interpretable model to identify young BC survivors at risk of developing CVDs.Methods: We designed and trained a Bayesian network (BN), an AI model, making use of expert knowledge and data from population-based (1036 patients) and clinical (339 patient) cohorts of female AYA (i.e., aged 18 to 39 years) 1-year survivors of BC, diagnosed in 2009–2019. The performance achieved by the BN model was validated against standard classification metrics, and two clinical applications were proposed.Results: The model showed a very good classification performance and a clear causal semantic. According to the predictions made by the model, focusing on the 25% of AYA BC survivors at higher risk of developing CVDs, we could identify 81% of the patients who would actually develop it. Moreover, a desktop-based app was implemented to calculate the individual patient’s risk.Conclusions: In this study, we developed the first causal model for predicting the CVD risk in AYA survivors of BC, also proposing an innovative AI approach that could be useful for all researchers dealing with RWD. The model could be pivotal for clinicians who aim to plan personalized follow-up strategies for AYA BC survivors.
KW - Adolescents and young adults
KW - Artificial Intelligence (AI)
KW - Breast cancer
KW - Cardiotoxic treatments
KW - Personalized follow-up
KW - Risk prediction
KW - Survivorship
UR - http://www.scopus.com/inward/record.url?scp=85208396596&partnerID=8YFLogxK
U2 - 10.3390/cancers16213643
DO - 10.3390/cancers16213643
M3 - Article
AN - SCOPUS:85208396596
SN - 2072-6694
VL - 16
JO - Cancers
JF - Cancers
IS - 21
M1 - 3643
ER -